Two Different Snapshots of the Same System
Fasting glucose is a single point-in-time measurement, taken after at least eight hours without food, of how much sugar is in the blood at that moment. HbA1c works differently. It measures the percentage of hemoglobin, the protein inside red blood cells, that has glucose attached to it. Because a red blood cell lives roughly 90 to 120 days, that percentage reflects an average of blood sugar exposure over the prior two to three months rather than any single day.
Neither number replaces the other. Fasting glucose tells you where blood sugar sits this morning. HbA1c tells you what the pattern has looked like over the last few months. Read together, they answer two different questions instead of confirming the same one twice.
Reference Ranges
Both tests use the same three-tier framework, normal, prediabetes, and diabetes range, but the numbers themselves are not interchangeable since they're measuring different things.
| Marker | Normal | Prediabetes | Diabetes Range |
|---|---|---|---|
| Fasting Glucose | Under 100 mg/dL | 100-125 mg/dL | 126 mg/dL or higher |
| HbA1c | Under 5.7% | 5.7%-6.4% | 6.5% or higher |
General screening ranges, not a diagnosis. These are the ranges used across most labs for screening purposes, but a single result sitting near a boundary, or two tests that disagree, is something to read with a clinician rather than self-diagnose from a chart.
Why Track Both
Fasting glucose can look fine on a day you happen to test well, missing patterns that show up at other times. Sleep the night before, stress, and ordinary day-to-day variation can all shift a single reading without reflecting an actual trend. HbA1c smooths that variability out by averaging exposure over months, but it can miss a sharp single-day spike, and it can be skewed independently by anything that affects red blood cell lifespan or turnover, a general point worth knowing rather than something to diagnose from a number on its own.
Together the two give a same-day view and a longer-arc view. Comparing them side by side over time, rather than reading either one in isolation, is what actually shows whether a change is holding up.
Relevance to a Peptide Protocol
Both markers are core tracking points for a metabolic-focused protocol, including GLP-1 compounds like Tirzepatide, where the goal is measurable improvement in both same-day blood sugar control and the longer-run average. Pairing fasting glucose and HbA1c with fasting insulin fills in the insulin sensitivity side of the picture, since a normal glucose reading can still sit on top of elevated insulin. For the full baseline panel these two markers belong to, see the peptide bloodwork guide, and for a closer look at HbA1c specifically, including how the assay can vary between labs, read the HbA1c explainer.
Once you have both numbers on hand, BioStackIQ's Analyze My Labs tool can read the report and flag anything worth a closer look against your current protocol.